What is Teckro, Inc.?
Teckro, Inc. provides a digital engagement platform designed to connect all stakeholders involved in clinical trials. The company's software solution is utilized by global pharmaceutical corporations and emerging biotechnology firms across all phases and therapeutic areas of clinical research. Headquartered in Limerick, Ireland, Teckro aims to streamline trial operations through enhanced communication and data accessibility, positioning itself as a critical technology provider in the life sciences industry.
How much funding has Teckro, Inc. raised?
Teckro, Inc. has raised a total of $41M across 3 funding rounds:
Series A
$6M
Series B
$10M
Series C
$25M
Series A (2016): $6M with participation from Enterprise Ireland and Founders Fund
Series B (2017): $10M led by Founders Fund, Section 32, and Sands Capital Ventures
Series C (2019): $25M supported by Sands Capital Ventures, Founders Fund, Section 32, Borealis Ventures, and Northpond Ventures
Key Investors in Teckro, Inc.
Enterprise Ireland
Enterprise Ireland is a government agency focused on developing and growing Irish businesses in manufacturing and internationally traded services, likely supporting Teckro's growth from its Irish base.
Founders Fund
Founders Fund is a venture capital firm known for investing in high-impact companies across various sectors and stages, often backing founders with ambitious visions.
Section 32
Section 32 is a venture capital firm specializing in cutting-edge technology, investing in innovative startups and emerging technologies with a focus on visionary entrepreneurs.
What's next for Teckro, Inc.?
The recent major strategic investment signals Teckro's readiness for accelerated scaling and market penetration. This capital infusion is expected to fuel further innovation in its clinical trial software, potentially expanding its service offerings and global reach. The company's consistent funding history, marked by significant rounds from Series A through C, indicates strong investor confidence in its business model and its capacity to address critical needs within the pharmaceutical and biotech sectors. Teckro is poised to further solidify its position as a leader in clinical trial technology.
See full Teckro, Inc. company page
